Healthcare Industry News: Eli Lilly
News Release - January 11, 2016
Bioventus Board of Managers Appoints Bill Hawkins ChairmanDURHAM, N.C.--(Healthcare Sales & Marketing Network)--Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Bill Hawkins, retired Chairman and CEO of Medtronic and currently Lead Director of Immucor, as its new Chairman of the company’s Board of Managers. Dan Lemaitre, who has served as Chairman since the inception of Bioventus in 2012, has decided to leave the company’s Board.
“I want to thank Dan Lemaitre for his vision, energy, sage counsel and leadership of our Board of Managers since Bioventus became a standalone company in 2012. His contributions to our early successes were numerous,” said Tony Bihl, CEO of Bioventus. “As we move into 2016, we are excited to have Bill Hawkins join us to lead our Board as Chairman. As former CEO of one of the most successful global medical device companies, Bill brings very strong experience in orthobiologics, including BMP, and we look forward to working with him and our Board to continue to grow Bioventus in this space.”
From October 2011 to July 2015, Hawkins served as President and CEO of Immucor, a leading provider of transfusion and transplantation diagnostic products worldwide. Prior to that, he served as Chairman and CEO of Medtronic. Previously, he served as President and CEO of Novoste Corp. Hawkins has also held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp., and Eli Lilly and Company.
Hawkins received his bachelor's degree in electrical and biomedical engineering from Duke University in 1976, where he also conducted medical research in pathology. He then went on to earn an MBA from the Darden School of Business, University of Virginia, in 1982. He is also active on public and private boards as well as non for profit boards.
Bioventus LLC is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.BioventusGlobal.com and follow the company on Twitter @Bioventusglobal
Bioventus and the Bioventus logo are registered trademarks of Bioventus.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.